All Stories

  1. Should we prescribe CPAP treatment in elderly patients with obstructive sleep apnea?
  2. Management options for excessive daytime sleepiness in patients with obstructive sleep apnea
  3. The interface in home non-invasive ventilation: is the nasal mask better?
  4. The modified Baveno classification for obstructive sleep apnoea: development and evaluation based on the ESADA database
  5. Comparative efficacy, safety and benefit/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysis
  6. Beat-to-beat cardiac repolarization lability increases during hypoxemia and arousals in obstructive sleep apnea patients
  7. Distance follow-up by a remote medical care centre improves adherence to CPAP in patients with obstructive sleep apnoea over the short and long term
  8. May continuous positive airway pressure (CPAP) treatment be detrimental in obstructive sleep apnea?
  9. REM sleep obstructive sleep apnoea
  10. Adaptive responses to chronic intermittent hypoxia: contributions from the European Sleep Apnoea Database (ESADA) Cohort
  11. What to expect from the ERS International Congress 2023
  12. Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea–COPD overlap syndrome: data from the European Sleep Apnoea Database
  13. Sympathetic activation in patients with heart failure and central sleep apnoea: is it friend or foe?
  14. Clinical characteristics and positive airway pressure adherence among elderly European sleep apnoea patients from the ESADA cohort
  15. Treatment options in obstructive sleep apnea
  16. Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome
  17. Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss: Longitudinal data from the ESADA
  18. Beneficial Role of Exercise in the Modulation of mdx Muscle Plastic Remodeling and Oxidative Stress
  19. Evaluation of a multicomponent grading system for obstructive sleep apnoea: the Baveno classification
  20. European Respiratory Society statement on sleep apnoea, sleepiness and driving risk
  21. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke
  22. Continuous professional development: elevating sleep andbreathing disorder education in Europe
  23. Sex differences in obstructive sleep apnoea
  24. New organisation for follow-up and assessment of treatment efficacy in sleep apnoea
  25. Obstructive sleep apnoea in acute coronary syndrome
  26. Unique sleep‐stage transitions determined by obstructive sleep apnea severity, age and gender
  27. Decrease in blood pressure during continuous positive airway pressure treatment for obstructive sleep apnoea: still searching for predictive factors
  28. Cancer prevalence is increased in females with sleep apnoea: data from the ESADA study
  29. Obstructive sleep apnea and comorbidities: a dangerous liaison
  30. Blood-pressure variability in patients with obstructive sleep apnea: current perspectives
  31. Beneficial Effects of CPAP Treatment in High-risk Subgroups of OSA Patients: Some Evidence, at Last
  32. Association of bronchial asthma with obstructive sleep apnea
  33. Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: longitudinal data from the ESADA cohort
  34. Sleep apnea and its role in transportation safety
  35. Abnormal thyroid hormones and non-thyroidal illness syndrome in obstructive sleep apnea, and effects of CPAP treatment
  36. Introducing a core curriculum for respiratory sleep practitioners
  37. Advances in asthma pathophysiology: stepping forward from the Maurizio Vignola experience: FIGURE 1
  38. Diabetes Mellitus Prevalence and Control in Sleep-Disordered Breathing
  39. Driving habits and risk factors for traffic accidents among sleep apnea patients - a European multi-centre cohort study
  40. Sleep apnoea severity independently predicts glycaemic health in nondiabetic subjects: the ESADA study
  41. Brain and Breathing
  42. Hyperuricemia and non-dipping blood pressure
  43. Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea
  44. Sleep apnoea and metabolic dysfunction
  45. Plasma leptin and vascular endothelial growth factor (VEGF) in normal subjects at high altitude (5050 m)
  46. Recommendations for the management of patients with obstructive sleep apnoea and hypertension
  47. Obesity and intermittent hypoxia increase tumor growth in a mouse model of sleep apnea
  48. Effects of exercise training on airway closure in asthmatics
  49. Position paper on the management of patients with obstructive sleep apnea and hypertension
  50. Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury
  51. Early and mid-term effects of obstructive apneas in myocardial injury and inflammation
  52. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea
  53. Reduced apoptosis of CD8+ T-Lymphocytes in the airways of smokers with mild/moderate COPD
  54. Adipose tissue in obesity and obstructive sleep apnoea
  55. Sleep HERMES: a European Core Syllabus in respiratory disorders during sleep
  56. Sleep HERMES: a European training project for respiratory sleep medicine
  57. Tissue Oxygenation in Brain, Muscle, and Fat in a Rat Model of Sleep Apnea: Differential Effect of Obstructive Apneas and Intermittent Hypoxia
  58. The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories
  59. Obstructive sleep apnoea and metabolic impairment in severe obesity
  60. Blood Pressure Changes After Automatic and Fixed CPAP in Obstructive Sleep Apnea: Relationship with Nocturnal Sympathetic Activity
  61. Obstructive sleep apnoea and metabolic syndrome in Mediterranean countries
  62. Management of obstructive sleep apnea in Europe
  63. Effects of exercise training on airway responsiveness and airway cells in healthy subjects
  64. Hemopoietic and angiogenetic progenitors in healthy athletes: different responses to endurance and maximal exercise
  65. Bronchial epithelial damage after a half-marathon in nonasthmatic amateur runners
  66. Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-BMI
  67. Environmental conditions, air pollutants, and airway cells in runners: A longitudinal field study
  68. Sleep, sleep-disordered breathing and metabolic consequences
  69. Metabolic aspects of obstructive sleep apnoea syndrome
  70. Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells
  71. Medico-legal implications of sleep apnoea syndrome: Driving license regulations in Europe
  72. Effects of Exercise Training and Montelukast in Children with Mild Asthma
  73. Bronchial responsiveness and airway inflammation in trained subjects
  74. Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk
  75. Endurance Training Damages Small Airway Epithelium in Mice
  76. "SLEEP APNOEA AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASE: CURRENT EVIDENCE, BASIC MECHANISMS AND RESEARCH PRIORITIES". W.T. MCNICHOLAS, M.R. BONSIGNORE AND THE MANAGEMENT COMMITTEE OF EU COST ACTION B26. EUR RESPIR J 2007; 29: 156-178.
  77. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
  78. Circulating CD34+ Cells Are Decreased in Chronic Obstructive Pulmonary Disease
  79. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD
  80. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP
  81. Commentary on Point-Counterpoint
  82. Reduced Airway Responsiveness in Nonelite Runners
  83. Supramaximal exercise mobilizes hematopoietic progenitors and reticulocytes in athletes
  84. “Light” smoking and dependence symptoms in high-school students
  85. Airway Cell Composition at Rest and after an All-out Test in Competitive Rowers
  86. Airway inflammation in patients affected by obstructive sleep apnea syndrome
  87. Increased airway inflammatory cells in endurance athletes: what do they mean?
  88. Continuous Positive Airway Pressure Treatment Improves Baroreflex Control of Heart Rate during Sleep in Severe Obstructive Sleep Apnea Syndrome
  89. Pulmonary haemodynamics in obstructive sleep apnoea
  90. Sleep apnoea and hypertension
  91. Sleep Structure Correlates of Continuous Positive Airway Pressure Variations During Application of an Autotitrating Continuous Positive Airway Pressure Machine in Patients With Obstructive Sleep Apnea Syndrome
  92. Influence of sampling interval on the evaluation of nocturnal blood pressure in subjects with and without obstructive sleep apnoea
  93. Myocardial ischemia during sleep
  94. Ventilation and entrainment of breathing during cycling and running in triathletes
  95. Gender and the Systemic Hypertension-Snoring Association: a Questionnaire-based Case-control Study
  96. Autonomic cardiac regulation in obstructive sleep apnea syndrome
  97. Slow and fast changes in transmural pulmonary artery pressure in obstructive sleep apnoea